Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

        Guidance, Compliance, & Regulatory Information

Postmarketing Requirements and Commitments: Introduction

                        
                Postmarketing Requirements and Commitments: Reports
          Postmarketing Requirements and Commitments: Legislative Background
          Postmarketing Requirements and Commitments: Frequently Asked Questions (FAQ)
          Postmarketing Requirements and Commitments: Downloadable Database File
          Postmarketing Requirements and Commitments: Status and Fulfillment Categories Home
          Drugs
          Guidance, Compliance, & Regulatory Information
          Postmarketing Requirements and Commitments: IntroductionGuidance, Compliance, & Regulatory Information Postmarketing Requirements and Commitments: Introduction
  	
        Share
    Post
    Linkedin

    Email
    Print**Databases**  Search: Postmarketing Requirements and Commitments for Human Drugs  Search: Post Approval Studies for Medical Devices**Introduction**  This Web site is intended to provide information to the public on postmarketing requirements and commitments. The phrase postmarketing requirements and commitments refers to studies and clinical trials that sponsors conduct after approval to gather additional information about a product's safety, efficacy, or optimal use. Some of the studies and clinical trials may be required; others may be studies or clinical trials a sponsor has committed to conduct.  The Agency has made available on this Web site a searchable database of information on postmarketing studies and clinical trials for drugs and biological products.  Frequently asked questions and answers have been developed to provide additional guidance.Postmarketing *requirements* (PMRs) include studies and clinical trials that sponsors are ***required*** to conduct under one or more statutes or regulations (see Background).  Postmarketing *commitments* (PMCs) are studies or clinical trials that a sponsor has agreed to conduct, but that are ***not required*** by a statute or regulation.  In the past, we have used the word *commitment* to cover both required and not required studies and clinical trials.  Now, because commitments and requirements are treated differently under the law, we are using terminology that distinguishes between studies and clinical trials that are required and those that a sponsor agrees to conduct that are not required.  Commitments containing proprietary information (e.g., those to evaluate chemistry or manufacturing and control issues) are not included on this Web site.  **What Studies or Clinical Trials Can Be Required Today?**  The studies and clinical trials that can be required under FDAAA join the types of studies and clinical trials that FDA could require before FDAAA.   Before FDAAA, FDA could require the following studies or clinical trials:  Postmarketing studies or clinical trials to demonstrate clinical benefit for drugs approved under the accelerated approval requirements in 21 CFR 314.510 and 21 CFR 601.41  Deferred pediatric studies (21 CFR 314.55(b) and 601.27(b)), where studies are required under the Pediatric Research Equity Act (PREA)  Studies or clinical trials to demonstrate safety and efficacy in humans that must be conducted at the time of use of products approved under the Animal Efficacy Rule (21 CFR 314.610(b)(1) and 601.91(b)(1))Now, under FDAAA, postmarketing studies and clinical trials also can be required to:  Assess a known serious risk related to the use of the drug  Assess signals of serious risk related to the use of the drug  Identify an unexpected serious risk when available data indicate the potential for a serious risk**What Has Changed on this Web Site Since the Enactment of FDAAA?**  This Web site contains information about postmarketing studies and clinical trials previously reported under the Modernization Act (both requirements and commitments), and it also contains information about studies and clinical trials required under FDAAA. Some changes have been made.  PMR refers to postmarketing requirements, studies or clinical trials the sponsor is required to conduct  PMC now refers to postmarketing commitments, studies or clinical trials to which sponsors commit but that they are not required to conduct  Changes have been made to the searchable database of information on postmarketing studies and clinical trials for drugs and biological products.  Frequently asked questions have been updated to reflect the changes resulting from FDAAA.

                                                                                  Content current as of:
      01/12/2016Postmarketing Requirements and Commitments: Introduction                
                          

                        Postmarketing Requirements and Commitments: Reports
          Postmarketing Requirements and Commitments: Legislative Background
          Postmarketing Requirements and Commitments: Frequently Asked Questions (FAQ)
          Postmarketing Requirements and Commitments: Downloadable Database File
          Postmarketing Requirements and Commitments: Status and Fulfillment Categories
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop